The axial spondyloarthritis (axSpA) treatment market encompasses drugs and therapies for treating the chronic inflammatory disease axial spondyloarthritis. Axial spondyloarthritis primarily affects the sacroiliac joints and spine, causing pain, morning stiffness, fatigue, and loss of mobility. Biologics such as anti-TNF therapies have revolutionized the treatment of axial spondyloarth... https://www.zupyak.com/p/4489322/t/axial-spondyloarthritis-axspa-treatment-market-poised-to-witness-high-growth-due-to-rising-prevalence-of-axial-spondyloarthritis-disorders